A randomized, unicenter, parallel study of the effect of dapagliflozin on central blood pressure reduction compared to glimepiride in adult subjects with type 2 Diabetes Mellitus and inadequate glycemic control.
Phase of Trial: Phase IV
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Dapagliflozin (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 28 Mar 2017 Status changed from not yet recruiting to recruiting.
- 27 Sep 2016 New trial record